Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Youmei Biotechnology is a specialized biotechnology firm headquartered in Changsha, China, focusing on the development of recombinant collagen-based medical and aesthetic products. The company utilizes a proprietary recombinant humanized collagen platform to produce high-purity proteins for skin repair, wound management, and anti-aging applications. Their commercial portfolio includes medical-grade dressings, gels, and skincare solutions marketed under the U-MAY brand, primarily targeting the dermatology and medical aesthetics markets. Hunan Youmei operates integrated R&D and manufacturing facilities that adhere to GMP standards for medical devices and biologics. The company's technology aims to replace animal-derived collagen with bio-engineered alternatives to reduce immunogenicity and improve clinical outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Youmei Biotechnology.